CSE’s Barrington Miller catches up with Timothy Ko, CEO of Entheon Biomedical Corp. (CSE:ENBI) to discuss how his company is pursuing R&D of DMT-based products to safely treat addiction. Timothy provides an update on what the company has accomplished in the year since they’ve been public and upcoming plans for clinical trials.
Here’s an overview of what Barrington and Timothy cover in this edition of the “Exchange for Entrepreneurs” podcast:
0:00 – Catching up with Timothy Ko and Entheon Biomedical
2:30 – What has happened since they listed on the CSE – Canadian Securities Exchange
4:12 – Personalization through genetics
6:20 – The genetics test kit
8:30 – Pathway for clinical trials
9:55 – What’s coming next for investors
About Entheon Biomedical Corp.
Entheon is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (“DMT Products”) for the purposes of treating addiction and substance use disorders. Subject to obtaining all requisite regulatory approvals and permits, Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics and licensed psychiatrists in the United States, certain countries in the European Union and throughout Canada.
Learn more about Entheon Biomedical Corp. at Entheon Biomedical Corp. | CSE – Canadian Securities Exchange (thecse.com)
CSE’s Barrington Miller chats with Johnson Joseph, CEO of Peak Fintech Group Inc. (CSE:PKK) to discuss how his company is building an ecosystem where small and medium businesses (“SMEs”) can easily connect with lending financial institutions to more efficiently access credit.
Here’s an overview of what Barrington and Johnson cover in this edition of the “Exchange for Entrepreneurs” podcast:
0:00 – Introducing Johnson Joseph and Peak Fintech Group
1:13 – Matching small businesses with the right lending opportunities
3:35 – The surprising use-case for their lending platform
5:12 – The technology at the core of Peak’s business
7:28 – The problem that SMEs have accessing credit
8:00 – From “lending hub” to “business hub”
11:38 – Using analytics and AI for lending decision making and ensuring privacy
14:40 – Doing business in China OVER 10 YEARS
19:21 – What’s coming next for investors
21:44 – Dumplings!
About Peak Fintech Group Inc.
Peak Fintech Group Inc. is the parent company of a group of innovative financial technology (Fintech) subsidiaries operating primarily in the commercial lending industry. Peak’s subsidiaries bring together lending financial institutions and businesses to create the Cubeler Business Hub, an ecosystem where analytics and artificial intelligence are used to facilitate transactions among members of the ecosystem.
Learn more about Peak Fintech Group Inc. at Peak Fintech Group Inc. | CSE – Canadian Securities Exchange (thecse.com)
CSE’s Barrington Miller chats with Ilan Sobel, CEO of BioHarvest Sciences Inc. (CSE:BHSC) to discuss how his company is combining science & technology with the power of nature to develop breakthrough proprietary and patented Biofarming technologies (plant cell growth).
Here’s an overview of what Barrington and Ilan cover in this edition of the podcast:
0:00 – Introducing Ilan Sobel and BioHarvest Sciences
2:45 – What Ilan learned over 18 years at Coca Cola
6:40 – Developing “Biofarming” technology at BioHarvest
10:20 – Incorporating sustainability into their strategies
13:25 – The intersection of biotech and health and wellness
16:15 – Correlating sustainable technologies and cost
19:55 – Advocating for female leadership in biotechnology
25:00 – Building “human utility value”
About BioHarvest Sciences Inc.
BioHarvest Sciences produces and sells a food-based Nutraceutical product called Vinia™ which contains the whole range of piceid resveratrol in natural state. The product is made by growing plant cells from red grapes in bioreactors utilizing BioHarvest’s platform technology which allows the growing of specific cells instead of the whole plant. BioHarvest Sciences is also completing research to adapt its platform technology to the growing of cannabis cells under a cannabis research license in Israel.
Learn more about BioHarvest Sciences Inc. at https://thecse.com/en/listings/life-sciences/bioharvest-sciences-inc